Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Waidmann

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Liver Cancer|June 12, 2018
Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting AntiviralsFabian Finkelmeier, Georg Dultz, Kai-Henrik Peiffer, et al.
World Journal of Gastroenterology|October 12, 2013
SEMS vs cSEMS in duodenal and small bowel obstruction: high risk of migration in the covered stent groupOliver Waidmann, Jörg Trojan, Mireen Friedrich-Rust, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Low Platelet Count Predicts Reduced Survival in Potentially Resectable Hepatocellular CarcinomaChristopher Schrecker, Oliver Waidmann, Hanan El Youzouri, et al.
GMS Hygiene and Infection Control|July 21, 2020
Impact of surface disinfection with hydrogen peroxide on the prevalence of vancomycin-resistant enterococci (VRE) in hospital wardsAnna Häring, Ursel Heudorf, Martin Exner, et al.
The Journal of Biological Chemistry|October 6, 2009
Inhibition of the equilibrative nucleoside transporter 1 and activation of A2A adenosine receptors by 8-(4-chlorophenylthio)-modified cAMP analogs and their hydrolytic productsOliver Waidmann, Thomas Pleli, Karel Dvorak, et al.
Digestion|August 22, 2018
Anti-EGF Receptor-Based Conversion Chemotherapy in RAS Wild-Type Colorectal Cancer Patients: Impact on Survival and Resection RatesChristine Koch, Niklas Schmidt, Ria Winkelmann, et al.
Journal of Hepatology|July 23, 2017
Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre studyPhilippe Kolly, Oliver Waidmann, Johannes Vermehren, et al.
Translational Oncology|June 5, 2013
High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular CarcinomaDominik Bergis, Valentin Kassis, Annika Ranglack, et al.
Oncology Research and Treatment|December 7, 2021
Sequence Therapy with FOLFIRINOX and Gemcitabine/Nab-Paclitaxel for Patients with Advanced Pancreatic Cancer: A Monocentre Retrospective Cohort StudyAlexander Queck, Sharra Elango, Christine Koch, et al.
Journal of Cancer Research and Clinical Oncology|October 31, 2018
Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centersFabian Finkelmeier, Carolin Czauderna, Lukas Perkhofer, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Liver Cancer|June 12, 2018
Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting AntiviralsFabian Finkelmeier, Georg Dultz, Kai-Henrik Peiffer, et al.
World Journal of Gastroenterology|October 12, 2013
SEMS vs cSEMS in duodenal and small bowel obstruction: high risk of migration in the covered stent groupOliver Waidmann, Jörg Trojan, Mireen Friedrich-Rust, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Low Platelet Count Predicts Reduced Survival in Potentially Resectable Hepatocellular CarcinomaChristopher Schrecker, Oliver Waidmann, Hanan El Youzouri, et al.
GMS Hygiene and Infection Control|July 21, 2020
Impact of surface disinfection with hydrogen peroxide on the prevalence of vancomycin-resistant enterococci (VRE) in hospital wardsAnna Häring, Ursel Heudorf, Martin Exner, et al.
The Journal of Biological Chemistry|October 6, 2009
Inhibition of the equilibrative nucleoside transporter 1 and activation of A2A adenosine receptors by 8-(4-chlorophenylthio)-modified cAMP analogs and their hydrolytic productsOliver Waidmann, Thomas Pleli, Karel Dvorak, et al.
Digestion|August 22, 2018
Anti-EGF Receptor-Based Conversion Chemotherapy in RAS Wild-Type Colorectal Cancer Patients: Impact on Survival and Resection RatesChristine Koch, Niklas Schmidt, Ria Winkelmann, et al.
Journal of Hepatology|July 23, 2017
Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre studyPhilippe Kolly, Oliver Waidmann, Johannes Vermehren, et al.
Translational Oncology|June 5, 2013
High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular CarcinomaDominik Bergis, Valentin Kassis, Annika Ranglack, et al.
Oncology Research and Treatment|December 7, 2021
Sequence Therapy with FOLFIRINOX and Gemcitabine/Nab-Paclitaxel for Patients with Advanced Pancreatic Cancer: A Monocentre Retrospective Cohort StudyAlexander Queck, Sharra Elango, Christine Koch, et al.
Journal of Cancer Research and Clinical Oncology|October 31, 2018
Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centersFabian Finkelmeier, Carolin Czauderna, Lukas Perkhofer, et al.
Pageof 12